Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Sources
sec edgar · verbatim disclosureEach tie, with the sentence that disclosed it. Open a row for the wording and the filing it came from.
“The Varseta-M payload is a topoisomerase-1 inhibitor licensed from AbbVie (formerly ImmunoGen), tailored to have anti-tumor activity against EpCAM-expressing cancer types.”
FILING10-K0001193125-26-107146cik 0001501989
“In the second quarter of 2024, CytomX announced a clinical collaboration with Merck to supply KEYTRUDA for evaluation of its combination with CX-801 in the Phase 1 study.”
FILING10-K0001193125-26-107146cik 0001501989
“Concurrent with the entry into the Amgen Agreement, Amgen purchased 1,156,069 shares of our common stock for $20.0 million.”
FILING10-K0001193125-26-107146cik 0001501989
“Pursuant to the BMS Agreement, the financial consideration from Bristol Myers Squibb was comprised of an upfront payment of $50.0 million and estimated research and development service fees, and we were initially entitled to receive contingent payments of up to $25.0 million for additional targets and contingent payments for development, regulatory and sales milestones.”
FILING10-K0001193125-26-107146cik 0001501989
“Under the terms of the Moderna Agreement, Moderna made an upfront payment to us of $35.0 million, including $5.0 million of pre-paid research funding which was subsequently utilized by Moderna.”
FILING10-K0001193125-26-107146cik 0001501989
“Pursuant to the Regeneron Agreement, Regeneron made an upfront payment of $30.0 million to us.”
FILING10-K0001193125-26-107146cik 0001501989
“At the initiation of the collaboration, we had the option to select from programs specified in the Amgen Agreement, an existing preclinical stage TCE product from the Amgen preclinical pipeline.”
FILING10-K0001193125-26-107146cik 0001501989
“In February 2020, we initiated an at-the-market offering program ("ATM") pursuant to a sales agreement with Jefferies, LLC (as amended on March 4, 2022 and August 9, 2024, the "Sales Agreement").”
FILING10-K0001193125-26-107146cik 0001501989
“• a one-time milestone payment of $5.0 million to ImmunoGen in prior year;”
FILING10-K0001193125-26-107146cik 0001501989
“In August 2010, we entered into an agreement with UCSB, that grants us an exclusive license, with the right to sublicense, under the patent rights owned by UCSB covering mask and screening technologies relating to the identification and discovery of pro-protein biologics, including masks and substrates, for the identification of pro-proteins, for use in the fields of therapeutics, in vivo diagnostics, and prophylactics (the "UCSB Agreement").”
FILING10-K0001193125-26-107146cik 0001501989
“Under the terms of the Astellas Agreement, we received an upfront payment of $80.0 million, and Astellas was responsible for funding the cost of preclinical research and discovery activities of both parties for all Products and for funding the cost of development and commercialization of all Products worldwide.”
FILING10-K0001193125-26-107146cik 0001501989
Watchlist prices, news filtered to it, and its next report on your desk.
Prev close 2.68 · gapped above the open, never looked back. High/low 3.19 at 8:45 am ET, 2.68 at 3:45 pm ET.
CytomX Therapeutics, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Pharmaceutical Preparations
CytomX Therapeutics, Inc. has 6 disclosed suppliers and 5 disclosed customers. Each one is named in an SEC filing, either CytomX Therapeutics, Inc.’s own annual report or the counterparty’s, and carries the sentence that discloses it.
CTMX (CytomX Therapeutics, Inc.) has 6 disclosed suppliers and 5 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
Largest move on the map today: JEF −2.47%, in financials.